119 related articles for article (PubMed ID: 35124694)
1. Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.
Husby S; Jørgensen GØ; Favero F; Jespersen JS; Rodriguez-Gonzalez FG; Nielsen C; Sorensen B; Ebbesen LH; Bæch J; Haastrup EK; Josefsson P; Thorsgaard M; Brown P; El-Galaly TC; Larsen TS; Weischenfeldt J; Grønbæk K
Bone Marrow Transplant; 2022 Apr; 57(4):674-677. PubMed ID: 35124694
[No Abstract] [Full Text] [Related]
2. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
3. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.
Husby S; Favero F; Nielsen C; Sørensen BS; Bæch J; Grell K; Hansen JW; Rodriguez-Gonzalez FG; Haastrup EK; Fischer-Nielsen A; Andersen P; Arboe B; Sækmose SG; Hansen PB; Christiansen I; Clasen-Linde E; Meldgaard L; Ebbesen LH; Segel EK; Josefsson P; Thorsgaard M; El-Galaly TC; Brown P; Weischenfeldt J; Larsen TS; Grønbæk K
Leukemia; 2020 Dec; 34(12):3256-3268. PubMed ID: 32203146
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Kerndrup GB; Hansen MC; Ewald IKL; Bill M; Ebbesen LH; Rosenberg CA; Hokland P; Ludvigsen M; Stidsholt Roug A
Blood Adv; 2020 Mar; 4(5):885-892. PubMed ID: 32150606
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis in hematopoietic stem cell transplantation.
Wilk CM; Manz MG; Boettcher S
Curr Opin Hematol; 2021 Mar; 28(2):94-100. PubMed ID: 33394723
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.
Akhtari M; Bhatt VR; Tandra PK; Krishnamurthy J; Horstman H; Dreessen A; Chen PX; Armitage JO
Cancer Biol Ther; 2013 Dec; 14(12):1077-88. PubMed ID: 24025414
[TBL] [Abstract][Full Text] [Related]
8. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era.
Mathys A; Bacher U; Banz Y; Legros M; Mansouri Taleghani B; Novak U; Pabst T
Hematol Oncol; 2022 Apr; 40(2):292-296. PubMed ID: 34817087
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study.
Mach-Pascual S; Legare RD; Lu D; Kroon M; Neuberg D; Tantravahi R; Stone RM; Freedman AS; Nadler LM; Gribben JG; Gilliland DG
Blood; 1998 Jun; 91(12):4496-503. PubMed ID: 9616144
[TBL] [Abstract][Full Text] [Related]
11. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
[TBL] [Abstract][Full Text] [Related]
12. The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.
Noring K; Carlsten M; Sonnevi K; Wahlin BE
BMC Cancer; 2021 May; 21(1):500. PubMed ID: 33947353
[TBL] [Abstract][Full Text] [Related]
13. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Maakaron JE; Liscynesky C; Boghdadly ZE; Huang Y; Agyeman A; Brammer J; Penza S; Efebera Y; Benson D; Rosko A; William B; Jaglowski SM
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e198-e201. PubMed ID: 32304873
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
[TBL] [Abstract][Full Text] [Related]
16. CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas.
Cao Y; Xiao Y; Wang N; Wang G; Huang L; Hong Z; Meng L; Zhou X; Wang J; Yang Y; Xu H; Zhang S; Xiao M; Chen L; Zheng M; Li C; Mao X; Gu C; Zhang T; Zhang Y; Zhou J
Transplant Cell Ther; 2021 Nov; 27(11):910.e1-910.e11. PubMed ID: 34425260
[TBL] [Abstract][Full Text] [Related]
17. Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation.
Bai B; Gao Y; Wang XX; He HX; Ping LQ; Li PF; Huang C; Cai QC; Huang HQ
Leuk Lymphoma; 2020 Dec; 61(14):3404-3411. PubMed ID: 32815763
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT; Rybicki LA; Urban TA; Lucena M; Jagadeesh D; Gerds AT; Dean RM; Sobecks RM; Pohlman B; Bolwell B; Kalaycio ME; Hamilton BK; Copelan EA; Majhail NS
Biol Blood Marrow Transplant; 2020 Feb; 26(2):262-271. PubMed ID: 31610237
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients.
Soligo DA; Lambertenghi Deliliers G; Servida F; Quirici N; Campiglio S; Tagliaferri E; Oriani A; Romitti L; Della Volpe A; Annaloro C
Bone Marrow Transplant; 1998 Jan; 21(1):15-22. PubMed ID: 9486489
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.
Maeng CH; Ko YH; Lim DH; Kang ES; Choi JY; Kim WS; Kim SJ
Cancer Res Treat; 2017 Jan; 49(1):92-103. PubMed ID: 27188204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
